Evidence map›Paper›PMID 27037373›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2016

Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.

Dhara Patel, Raed Alhawaj, Melissa R Kelly, John J O Accarino, Anand Lakhkar, Sachin A Gupte, Dong Sun, Michael S Wolin

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Oxidative Stress and Hypertension.Circulation research · 2021
    Review
  10. Review
  11. Eicosanoids and Oxidative Stress in Diabetic Retinopathy.Antioxidants (Basel, Switzerland) · 2020
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Redox regulation of soluble guanylyl cyclase.Nitric oxide : biology and chemistry · 2018
    Review
  17. Article
  18. Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.American journal of physiology. Heart and circulatory physiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dhara PatelDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and.
Raed AlhawajDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and.
Melissa R KellyDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and.
John J O AccarinoDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and.
Anand LakhkarDepartment of Pharmacology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York.
Sachin A GupteDepartment of Pharmacology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York.
Dong SunDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and.
Michael S WolinDepartment of Physiology, Translational Center for Pulmonary Hypertension, New York Medical College, Valhalla, New York and mike_wolin@nymc.edu.
New York Medical College · US

Funding

Ferrochelatase & guanylate cyclase regulation in vascular dysfunctionR01HL129797 · NHLBI · NEW YORK MEDICAL COLLEGE · PI SUN, DONG, WOLIN, MICHAEL S · 2016 to 2019
$1.6M
ecSOD derived peroxide in pulmonary adaptation to hypoxiaR01HL115124 · NHLBI · NEW YORK MEDICAL COLLEGE · PI WOLIN, MICHAEL S · 2013 to 2016
$1.6M
NHLBI NIH HHS R01 HL115124NHLBI NIH HHS R01 HL129797
6 · The paper itself

Abstract

Oxidation of the soluble guanylate cyclase (sGC) heme promotes loss of regulation by nitric oxide (NO) and depletion of sGC. We hypothesized that angiotensin II (ANG II) stimulation of mitochondrial superoxide by its type 1 receptor could function as a potential inhibitor of heme biosynthesis by ferrochelatase, and this could decrease vascular responsiveness to NO by depleting sGC. These processes were investigated in a 24-h organoid culture model of bovine coronary arteries (BCA) with 0.1 μM ANG II. Treatment of BCA with ANG II increased mitochondrial superoxide, depleted mitochondrial superoxide dismutase (SOD2), ferrochelatase, and cytochrome oxidase subunit 4, and sGC, associated with impairment of relaxation to NO. These processes were attenuated by organoid culture with 8-bromo-cGMP and/or δ-aminolevulinic acid (a stimulator of sGC by protoporphyrin IX generation and heme biosynthesis). Organoid culture with Mito-TEMPOL, a scavenger of mitochondrial matrix superoxide, also attenuated ANG II-elicited ferrochelatase depletion and loss of relaxation to NO, whereas organoid culture with Tempol, an extramitochondrial scavenger of superoxide, attenuated the loss of relaxation to NO by ANG II, but not ferrochelatase depletion, suggesting cytosolic superoxide could be an initiating factor in the loss of sGC regulation by NO. The depletion of cytochrome oxidase subunit 4 and sGC (but not catalase) suggests that sGC expression may be very sensitive to depletion of heme caused by ANG II disrupting ferrochelatase activity by increasing mitochondrial superoxide. In addition, cGMP-dependent activation of protein kinase G appears to attenuate these ANG II-stimulated processes through both preventing SOD2 depletion and increases in mitochondrial and extramitochondrial superoxide.

Indexed as

Angiotensin IIAnimalsCattleCoronary VesselsCyclic GMP-Dependent Protein KinasesDown-RegulationElectron Transport Complex IVEnzyme ActivatorsFerrochelataseFree Radical ScavengersHemeMitochondriaNitric OxideNitric Oxide DonorsOrganoidsSoluble Guanylyl CyclaseAngiotensin IICyclic GMP-Dependent Protein KinasesElectron Transport Complex IVEnzyme ActivatorsFerrochelataseFree Radical ScavengersHemeNitric OxideNitric Oxide DonorsSoluble Guanylyl CyclaseSuperoxide DismutaseSuperoxide Dismutase 2SuperoxidesVasodilator Agentsguanosine 3′,5′-cyclic monophosphateprotoporphyrin IX, nitric oxideδ-aminolevulinic acid

Identifiers

PMID27037373
PMCPMC4935518
OpenAlexW2329395698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.